BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

$1.75
-0.04 (-2.23%)
As of Jun 30, 10:38 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,414.3% upside
Low Target $29.80
Average Target $44.00
High Target $55.04
Current Price $1.75
Current
$1.75
Target
$44.00
$29.80 $44.00 avg $55.04
Scenario Analysis
Bear Case
$29.80
1,602.9%
Low target
Base Case
$44.00
+2,414.3%
Avg target
Bull Case
$55.04
+3,045.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.62
-33.2% from high
52-Week Low
$1.18
+48.9% from low
Target vs 52W High
$44.00
+1,579.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%